Skip to content
Viseur AI - Digital Pathology Platform logo — Better disease diagnosis for everyone!

Viseur AI - Digital Pathology Platform

Better disease diagnosis for everyone!

Founded 2024 Turkey Turkey 15 employees Total: $650.00K AI, Health Care +1

General Information

Company Name Viseur AI - Digital Pathology Platform
Founded Year 2024
Location Turkey Turkey
Employees 15
Industries AI, Health Care, Life Sciences
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Usage Based, Marketplace Fee
Offices as of Sep 2026
Ankara, Turkey Helsinki, Finland
Social

BounceWatch is an independent company data service, not affiliated with Viseur AI - Digital Pathology Platform. To contact Viseur AI - Digital Pathology Platform, visit viseur.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Viseur AI - Digital Pathology Platform compare?

A PDF of Viseur AI - Digital Pathology Platform and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Viseur AI - Digital Pathology Platform soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Viseur AI - Digital Pathology Platform

Viseur AI, founded in 2024 and headquartered in Turkey, is a pioneering digital pathology platform that aims to revolutionize the field of medical diagnostics. With the slogan, "Better disease diagnosis for everyone!", the company is on a mission to streamline the fragmented and often inefficient workflows in pathology labs through its comprehensive, vendor-agnostic solution.

The platform integrates Pathology Information Management (PIMS), digital pathology viewing, AI model deployment, and governance into a unified system, enhancing standardization and scalability across healthcare networks. By addressing limitations in existing scanner-locked software and infrequent AI deployment, Viseur AI enables end-to-end solutions that support clinical workflows from specimen handling to reporting. The company is compliant with critical industry standards such as ISO 13485, ISO 27001, and ISO/IEC 15504-SPICE, reflecting its commitment to quality and security.

Currently operating in the AI, Healthcare, and Life Sciences sectors, Viseur AI secured a €300.00K early VC investment from APY Ventures in May 2026, indicating strong investor confidence in its innovative approach and market potential.

Business keywords: Digital Pathology, Medical Imaging, AI-Enabled Diagnostics, Pathology Information Management, AI Model Deployment, Clinical Workflow Integration, Healthcare IT Solutions, Enterprise-Grade Integrations, Digital Transformation in Healthcare, End-to-End Automation, Data Privacy in Healthcare, Vendor-Agnostic Platform, ISO Certification, Hybrid Architecture Solutions

Services & Products

Smart Radiology Platform
Digital Pathology Workflow
AI Workflow Integration
Healthcare Management Systems
Secure Data Management

Target Customers

Healthcare Professionals Clinicians Radiologists Pathologists Medical IT Teams

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €300.00K 1
APY Ventures
01 May 2026
Early VC €250.00K 3
Decacorn Angels, Kayacan Ventures +1
01 Mar 2025
Early VC €100.00K 1
Kayacan Ventures
01 Oct 2024
Spinout Undisclosed 1
Health Incubator Helsinki
01 Jan 2024

Viseur AI - Digital Pathology Platform Alternatives & Competitors

View All Alternatives
Viseur AI - Digital Pathology Platform vs

Unlocking power of clinical data.

Seed
15 employees
AI, Analytics
Viseur AI - Digital Pathology Platform vs
Autoscriber
Autoscriber The Netherlands

Enabling human centric, data-driven healthcare

Seed
17 employees
AI, Analytics
Viseur AI - Digital Pathology Platform vs
Ligence
Ligence Lithuania

Echocardiography workflow that makes sense

Seed
30 employees
AI, Analytics

FAQ About Viseur AI - Digital Pathology Platform

Better disease diagnosis for everyone!
Viseur AI - Digital Pathology Platform was founded in 2024.
Viseur AI - Digital Pathology Platform is headquartered in Turkey. As of Sep 2026, it also has offices in Ankara, Turkey and Helsinki, Finland.
Viseur AI - Digital Pathology Platform operates in AI, Health Care and Life Sciences. Its work centres on Digital Pathology, Medical Imaging, AI-Enabled Diagnostics and Pathology Information Management. Its customers include Healthcare Professionals, Clinicians and Radiologists.
Viseur AI - Digital Pathology Platform has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Usage Based and Marketplace Fee.
Viseur AI - Digital Pathology Platform has approximately 15 employees.
Viseur AI - Digital Pathology Platform has completed 4 funding rounds, raising a total of $650.00K.
Viseur AI - Digital Pathology Platform offers: Smart Radiology Platform, Digital Pathology Workflow, AI Workflow Integration, Healthcare Management Systems, Secure Data Management.
Top alternatives and competitors to Viseur AI - Digital Pathology Platform include CliniNote - unlocking clinical data, Autoscriber, Ligence, Avicenna.AI, deepc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Viseur AI - Digital Pathology Platform and CliniNote - unlocking clinical data are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Viseur AI - Digital Pathology Platform, https://bouncewatch.com/company/viseur-ai, updated 24 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout